PHASE Scientific Eng Logo.png
Indicaid Logo ENG TM RGB 2021.png

COVID-19 

RAPID ANTIGEN TEST

Authorised for Self-Test and Professional Use in Singapore by the Health Sciences Authority (HSA) under the Pandemic Special Access Route (PSAR) 

The INDICAID COVID-19 Rapid Antigen Test
Is a lateral flow immunoassay designed for the qualitative detection of SARS-CoV-2 antigens in direct nasal swab samples. 

INDICAID was developed by PHASE SCIENTIFIC, a Hong Kong biotech company with support from the Bill & Melinda Gates Foundation, US National Institutes of Health (NIH) and US National Science Foundation (NSF). 

blur-coronavirus-2019-ncov-white-background-medical-healthcare-microbiology-concept-design

INTENDED USE

  • Ideal option for the rapid detection of SARS-CoV-2 infection in symptomatic or asymptomatic individuals suspected of infection or in close-contacts with individuals who are COVID-19 positive.

  • Can be used anywhere, anytime by anyone regardless of vaccination or symptom status.

PRODUCT ADVANTAGES

  • Accurate : Clinically validated with overall sensitivity and specificity at 91% and 96% respectively 

  • Variants detectability : Able to detect the presence of certain COVID-19 variants, including Delta and Omicron variants.

  • Clinical Validation : tested in the world's largest clinical study with more than 23000 field samples.

  • Trusted brand : Widely adopted globally in hospitals, organizations, schools, restaurants, and retail stores

  • Market leader : The No.1 Rapid Test Kit in Hong Kong

INDICAID COVID-19 RAPID ANTIGEN TEST DEMO VIDEO

English Language

Cantonese Language

​INSTRUCTION STEPS FOR USE

RESULT INTERPRETATION

result_table-02.png
Picture11.png

25-Tests Kit

IN-COVAG-025SG01A

To download the INDICAID COVID-19 ART Instruction Guide

Picture13.png

1-Test Kit

IN-COVAG-001SG01A

To download the INDICAID COVID-19 ART Instruction Guide